Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Resomer used in commercial 3D-printed implants for both soft and hard tissue applications

Aptar appoints Julie Xing to its Board of Directors

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.

Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection

Rocuronium Bromide Injection is a neuromuscular blocking agent

Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products

This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.

Vaishali Pharma receives multiple orders worth US$ 73.85 million

This order is subject to initial advance payment as per the agreed terms of the contract

Dr. Reddy's Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio

The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region

Strides flagship facility in Bangalore receives USFDA inspection closure